CSTE’s Infectious Disease Steering Committee and its subcommittees are among the largest and most active groups within the organization. The CSTE Infectious Disease Steering Committee is home to several disease-specific subcommittees that meet regularly to discuss matters of importance, to update and/or create position statements for discussion at the CSTE Annual Conference, and to develop databases of information for various infectious diseases. The infectious disease subcommittees address issues related to enteric and foodborne diseases, healthcare associated infections (HAIs), HIV, STDs, influenza, immunization and vaccine preventable diseases, hepatitis, waterborne disease, and vectorborne and zoonotic diseases. Infectious disease subcommittee members also work collaboratively with other CSTE program areas (e.g., the Surveillance/Informatics Steering Committee) to facilitate the identification, investigation, diagnosis, treatment, and prevention of disease.
In alignment with their respective state, local, and territorial health departments, CSTE members collaborate with federal public health programs (e.g., CDC, FDA, and USDA) and partner organizations (e.g., APHL, ASTHO, NACCHO, and NASTAD) to support projects related to infectious disease epidemiology. CSTE’s Infectious Disease Steering Committee participates in the annual process of developing and revising CSTE position statements related to case definitions for infectious diseases as well as updating the list of Nationally Notifiable Diseases.
NEW! CSTE is pleased to announce the release of the new report, Assessment of Capacity in 2012 for the Surveillance, Prevention and Control of West Nile Virus and Other Mosquito-borne Virus Infections in State and Large City/County Health Departments and How it Compares to 2004.
Report located here: http://www.cste2.org/docs/VBR.pdf
In 2013, CSTE conducted an assessment of vectorborne disease surveillance capacity with emphasis on West Nile virus (WNV) to better understand the existing arboviral surveillance capacity within state and select local health departments following decreases in Epidemiology and Laboratory Capacity (ELC) funding since 2004. A CSTE workgroup with representation from ASTHO, NACCHO, and APHL with technical assistance from the CDC developed an assessment to describe human, mosquito and laboratory surveillance capacity for WNV and other arboviruses in 2012, one of the most intense WNV seasons thus far, and to compare responses with those from a similar assessment conducted in 2004. CSTE distributed the assessment electronically in August 2013. All 50 states, all six CDC ELC grant recipient-supported city/county health departments, and 15 of 24 city/county health departments with no direct ELC support but high past levels of WNV activity responded. This report summarizes the assessment findings, which document a decrease in surveillance capacity since 2004. Most notably, human surveillance has become more passive, laboratory capacity has diminished, and mosquito surveillance activity has diminished to the point where some state and key local health departments no longer do it.
If you are interested in becoming more involved in the Infectious Disease Steering Committee, please click the topics below or contact CSTE – we welcome your involvement!